PMID- 21625315
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20110714
LR  - 20211020
IS  - 2035-3006 (Electronic)
IS  - 2035-3006 (Linking)
VI  - 3
IP  - 1
DP  - 2011
TI  - 5-azacytidine in chronic myelomonocytic leukemia: case report and review of 
      literature.
PG  - e2011011
LID - 10.4084/MJHID.2011.011 [doi]
LID - e2011011
AB  - Hypomethylating drugs are useful in the management of Myelodysplastic syndromes, 
      but there are only few reports on chronic myelomonocycitic (CMML) leukemia 
      patients. We describe our experience in 3 CMML patients treated with azacitidine. 
      Two patients obtained partial response after 4 treatment cycles with only minor 
      toxicity and are in continuous partial response, with stable peripheral blood 
      counts, at 29 and 30 cycles from treatment start.
FAU - Greco, M
AU  - Greco M
AD  - Istituto di Ematologia, Universita Cattolica Sacro Cuore, Rome, Italy.
FAU - Criscuolo, M
AU  - Criscuolo M
FAU - Fianchi, L
AU  - Fianchi L
FAU - Fabiani, E
AU  - Fabiani E
FAU - Pagano, L
AU  - Pagano L
FAU - Voso, Mt
AU  - Voso M
LA  - eng
PT  - Case Reports
DEP - 20110315
PL  - Italy
TA  - Mediterr J Hematol Infect Dis
JT  - Mediterranean journal of hematology and infectious diseases
JID - 101530512
PMC - PMC3103239
EDAT- 2011/06/01 06:00
MHDA- 2011/06/01 06:01
PMCR- 2011/01/01
CRDT- 2011/06/01 06:00
PHST- 2011/01/12 00:00 [received]
PHST- 2011/03/03 00:00 [accepted]
PHST- 2011/06/01 06:00 [entrez]
PHST- 2011/06/01 06:00 [pubmed]
PHST- 2011/06/01 06:01 [medline]
PHST- 2011/01/01 00:00 [pmc-release]
AID - mjhid-3-e2011011 [pii]
AID - 10.4084/MJHID.2011.011 [doi]
PST - ppublish
SO  - Mediterr J Hematol Infect Dis. 2011;3(1):e2011011. doi: 10.4084/MJHID.2011.011. 
      Epub 2011 Mar 15.